导航
| 统计阶段 | 收益率 | 同类排名 |
|---|---|---|
| 今年以来 | -4.59% | 692/1050 |
| 近一周 | -2.71% | 699/1104 |
| 近一月 | -4.52% | 559/1102 |
| 近一季 | -6.20% | 473/1092 |
| 近半年 | -11.02% | 795/1070 |
| 近一年 | -3.99% | 643/1018 |
| 近两年 | 41.54% | 566/926 |
| 近三年 | 25.82% | 423/834 |
| 成立以来 | 242.32% | - |
| 年份 | 年收益 | 1季度 | 2季度 | 3季度 | 4季度 |
| 2026 | - - |
-1.49% 596/1070 |
5.39% 614/1101 |
- - |
- - |
| 2025 | 28.13% 507/1065 |
2.78% 568/1014 |
4.25% 344/1038 |
27.33% 405/1050 |
-6.08% 743/1065 |
| 2024 | 7.00% 358/1011 |
0.15% 300/960 |
7.17% 45/983 |
2.05% 935/991 |
-2.31% 474/1011 |
| 2023 | -13.67% 462/952 |
1.34% 550/880 |
0.48% 161/895 |
-13.69% 744/915 |
-1.77% 212/952 |
| 2022 | -26.02% 529/867 |
-21.65% 619/773 |
14.20% 142/806 |
-18.26% 717/845 |
1.15% 375/867 |
| 2021 | 119.42% 1/740 |
-10.05% 491/580 |
60.71% 1/659 |
32.30% 1/704 |
14.74% 25/740 |
| 2020 | 56.99% 206/554 |
-10.22% 383/419 |
5.68% 412/466 |
16.10% 128/517 |
42.51% 9/554 |
| 2019 | 8.34% 343/410 |
4.24% 1069/1146 |
0.37% 291/1228 |
2.65% 262/390 |
0.88% 383/410 |
| 2018 | - - |
- - |
-1.17% 101/990 |
0.50% 158/1000 |
-1.63% 24/1080 |
| 2017 | - - |
- - |
- - |
- - |
- - |
| 2016 | - - |
- - |
- - |
- - |
- - |
| 2015 | - - |
- - |
- - |
- - |
- - |
| 2014 | - - |
- - |
- - |
- - |
- - |
| 2013 | - - |
- - |
- - |
- - |
- - |
| 2012 | - - |
- - |
- - |
- - |
- - |
| 基金名称 | 最新净值 | 季增长率 |
| 招商前沿医疗保健股票A | 0.8316 | 54.00% |
| 招商前沿医疗保健股票C | 0.7978 | 53.69% |
| 招商医药健康产业股票 | 2.5730 | 48.73% |
| 嘉实医疗保健股票 | 2.5780 | 39.05% |
| 广发医药精选股票A | 1.3132 | 38.48% |
| 广发医药精选股票C | 1.2923 | 38.32% |
| 前海开源公共卫生股票A | 0.4690 | 37.42% |
| 前海开源公共卫生股票C | 0.4590 | 37.30% |
| 交银医药创新股票C | 3.0594 | 35.86% |
| 交银医药创新股票A | 2.8810 | 32.85% |
| 前海开源公用事业股票 VS. 东吴新产业精选股票A(580008) |